Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 7,735 | 10,773 | 9,653 | 10,412 | 8,352 |
| Gross Profit | 7,735 | 10,773 | 9,653 | 10,412 | 8,352 |
| Operating Expenses | 49,635 | 52,766 | 53,166 | 58,197 | 49,980 |
| Operating Income | -41,900 | -41,993 | -43,513 | -47,785 | -41,628 |
| Interest Expense | 3,403 | 3,403 | 3,403 | 3,523 | 3,520 |
| Other Income | 733 | 904 | 564 | 465 | 541 |
| Pre-tax Income | -44,570 | -44,492 | -46,352 | -50,843 | -44,607 |
| Net Income Continuous | -44,570 | -44,492 | -46,352 | -50,843 | -44,607 |
| Net Income | $-44,570 | $-44,492 | $-46,352 | $-50,843 | $-44,607 |
| EPS Basic Total Ops | -2.33 | -2.37 | -2.80 | -3.16 | -3.00 |
| EPS Basic Continuous Ops | -2.33 | -2.37 | -2.75 | -3.21 | -3.01 |
| EPS Diluted Total Ops | -2.33 | -2.37 | -2.80 | -3.16 | -3.00 |
| EPS Diluted Continuous Ops | -2.33 | -2.37 | -2.75 | -3.21 | -3.01 |
| EBITDA(a) | $-39,503 | $-39,580 | $-41,078 | $-45,307 | $-37,744 |